title: Immunological compatibility between the chacma baboon and man.
abstract: Predictions of an increasing shortage of donor organs for the future has led to a resurgence of interest in xenotransplantation. We have methodically assessed the immunological compatibility of humans against the chacma baboon with a view to narrowing the gap of concordance by careful immunological screening. The necessity of major blood group compatibility in xenotransplantation is now established. While no group O universal donor exists in the baboon, groups A (45%), B (15%), and AB (40%) are well represented. Baboon histocompatibility antigens could not be precisely defined using human antisera. This does not necessarily imply lack of homology between the species, as we have shown specific crossreactivity of numerous antihuman monoclonal antibodies with baboon leukocytes. Normal humans do not exhibit preformed agglutinins to erythrocytes of the chacma baboon (Papio ursinus orientalis)) but cytotoxic antibodies are occasionally found. Sera from allosensitized patients may contain crossreacting hemagglutinins, leukoagglutinins and complement-dependent cytotoxic antibodies. Binding of human immunoglobulin-G and -M to baboon targets was demonstrated by flow cytometry. Negative crossmatch combinations for antibodies of the IgG subclass were easily found, but IgM antibodies from allosensitized patients were polyspecific in their action. In vitro assessment of lymphocyte mediated cytotoxicity showed that preformed cellular immunity between the species was rare. The response of human lymphocytes to xenoantigen stimulation in mixed lymphocyte cultures showed a normal distribution, permitting the selection of low-responding combinations. Screening for viruses, especially HTLV-1 and Coxsackie-BL34, is important. These findings demonstrate a closer degree of concordance than has previously been suspected.
authors.affiliation: MRC Unit for Research in Organ Transplantation, Department of Surgery, University of the Witwatersrand Medical School, Johannesburg, South Africa.
authors.forename: J H
authors.initials: JH
authors.lastname: Stark
authors.forename: J A
authors.initials: JA
authors.lastname: Smit
authors.forename: F A
authors.initials: FA
authors.lastname: Neethling
authors.forename: P J
authors.initials: PJ
authors.lastname: Nortman
authors.forename: J A
authors.initials: JA
authors.lastname: Myburgh
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D001788:Blood Grouping and Crossmatching; D003429:Cross Reactions; D003602:Cytotoxicity, Immunologic; D006384:Hemagglutination; D006649:Histocompatibility Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006650:Histocompatibility Testing; D015368:Human T-lymphotropic virus 1 / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007959:Lymphocyte Culture Test, Mixed; D010215:Papio / Q000276:immunology*; D014183:Transplantation, Heterologous / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D006649:Histocompatibility Antigens; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II